"CRISPR" validation of recessive brain cancer genes in vivo
- PMID: 26203775
- PMCID: PMC4627218
- DOI: 10.18632/oncotarget.4864
"CRISPR" validation of recessive brain cancer genes in vivo
Keywords: CRISPR/Cas9; Chromosome Section; brain tumors; mouse models; somatic gene transfer.
Similar articles
-
Brain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the future.Oncotarget. 2016 May 31;7(22):33461-71. doi: 10.18632/oncotarget.8075. Oncotarget. 2016. PMID: 26993776 Free PMC article. Review.
-
CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.Gastroenterology. 2017 Dec;153(6):1662-1673.e10. doi: 10.1053/j.gastro.2017.09.008. Epub 2017 Sep 18. Gastroenterology. 2017. PMID: 28923495 Free PMC article.
-
Methods in Enzymology. The use of CRISPR/Cas9, ZFNs, and TALENs in generating site-specific genome alterations. Preface.Methods Enzymol. 2014;546:xix-xx. doi: 10.1016/B978-0-12-801185-0.09983-9. Methods Enzymol. 2014. PMID: 25398356 No abstract available.
-
Application of CRISPR/Cas9 genome editing to the study and treatment of disease.Arch Toxicol. 2015 Jul;89(7):1023-34. doi: 10.1007/s00204-015-1504-y. Epub 2015 Apr 1. Arch Toxicol. 2015. PMID: 25827103 Review.
-
Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma.Cancer Lett. 2016 Apr 1;373(1):109-118. doi: 10.1016/j.canlet.2016.01.030. Epub 2016 Jan 21. Cancer Lett. 2016. PMID: 26806808 Free PMC article. Review.
Cited by
-
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction.Curr Oncol. 2023 Feb 6;30(2):1954-1976. doi: 10.3390/curroncol30020152. Curr Oncol. 2023. PMID: 36826113 Free PMC article. Review.
-
Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles.Front Immunol. 2024 Aug 30;15:1444437. doi: 10.3389/fimmu.2024.1444437. eCollection 2024. Front Immunol. 2024. PMID: 39281673 Free PMC article. Review.
-
CRISPR-Cas9: a promising genetic engineering approach in cancer research.Ther Adv Med Oncol. 2018 Feb 5;10:1758834018755089. doi: 10.1177/1758834018755089. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 29434679 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical